Latest Regulatory News

Tyranna Resources has withdrawn certain visual mineralisation estimates from its recent quarterly report, citing non-compliance with ASX reporting standards and urging investors to disregard these figures.

Kinetiko Energy reports robust gas production from test wells and secures a binding joint development agreement with FFS Refiners to advance a pilot LNG plant in South Africa, backed by a $3.15 million capital raise and new North American market listing.

Caravel Minerals has reached 90% completion of its Definitive Engineering Study for the Caravel Copper Project, secured a critical grid connection offer, and signed a strategic MoU with Adani’s Kutch Copper for offtake and potential investment.

Cokal Limited has advanced its metallurgical coal operations in Central Kalimantan with new mining contracts, resumed coal shipments, and infrastructure upgrades, aiming for a 2026 production target of approximately 420,000 tonnes.

QEM Limited is progressing its strategic review of the Julia Creek Vanadium and Energy Project while advancing key environmental studies and managing capital prudently.

Conrad Asia Energy has locked in a transformative farm-in and financing deal for its flagship Mako gas field, setting the stage for first gas in late 2027. The company also resolved historic disputes, strengthening its position in Indonesia’s growing gas market.

Clarity Pharmaceuticals reports robust progress in prostate cancer and neuroendocrine tumour trials alongside a strong cash position of $226.2 million, underpinning its path towards commercialisation.

Southern Palladium has made significant strides in advancing its Bengwenyama platinum group metals project, completing key drilling and regulatory milestones while securing A$20 million in fresh capital to fund the next development phase.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

4DMedical has rapidly commercialised its CT – VQ™ lung imaging technology following FDA clearance, securing major partnerships and regulatory approvals that position it for significant growth in North America.

Bathurst Resources reported a first-half FY26 EBITDA of NZD 16 million, maintaining its full-year guidance despite export challenges and cost pressures. Key development projects in New Zealand and Canada continue to advance steadily.

Cann Group Limited has reported its first-ever free cash flow positive quarter, following a significant debt restructuring and a $9 million capital raise. Despite a softer quarterly revenue, the company is advancing new product launches and export partnerships, positioning itself for growth.